Consulte los últimos artículos sobre la enfermedad de von Willebrand
Última actualización: Martes, 19 de marzo de 2024In the last several decades, the bleeding disorders community has seen an unprecedented evolution of novel therapies for treating inherited disorders. These therapies have included recombinant clotting...
Leer más
Von Willebrand disease (VWD) is a hemostatic disorder characterized by a quantitative or qualitative deficiency of the Von Willebrand factor (VWF). It affects males and females equally. This pathology...
Leer más
In order for patients to gain access to new pharmaceuticals, manufacturers must successfully navigate two critical steps. First, they need to obtain marketing approval (i.e., approval to market) from a...
Leer más
Patients with an unexplained mild to moderate bleeding tendency are diagnosed with bleeding disorder of unknown cause (BDUC), a classification reached after ruling out other mild to moderate bleeding disorders (MBD) including von Willebrand disease (VWD), platelet function defects (PFDs), coagulation factor deficiencies (CFDs), and non-hemostatic causes for bleeding. This review outlines our diagnostic approach to BDUC, a diagnosis of exclusion, drawing...
Leer más
1 Real-world evidence for coverage determination of treatments for rare diseases
Orphanet Journal of Rare Diseases 2024; 19(1): 47Refine su búsqueda de información científica
Búsqueda Avanzada ¿Necesita ayuda?